Clinical Trial Update: A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial evaluating sintilimab plus platinum doublet chemotherapy for stage IIIA(N2) non-small cell lung cancer is reported as ongoing with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-doublet chemotherapy
• Sintilimab (sintilimab)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN